Global HIV company Viiv Healthcare has launched its first new treatment option for people with HIV today.
US biotech firm Gilead Sciences (Nasdaq: GILD) yesterday announced full Phase III clinical trial results…
Anti-viralsAtriplaBiotechnologyGilead SciencesNorth AmericaQuadRegulationResearchTruvada
Our latest news direct to your inbox
Back to top